CJC-1295 a modified GHRH analog available in two forms: with DAC (Drug Affinity Complex) for extended action, or without DAC for shorter pulses
Ensure all training is documented to meet compliance standards
When to seek medical care A person should seek medical advice if they are considering any GLP-1-related product for weight loss or blood sugar control, especially if they have diabetes, prediabetes, obesity, high blood pressure, heart disease, kidney disease, or take regular medications
Although leg cramps are not listed as an official adverse effect in FDA prescribing information, understanding the potential indirect mechanismsincluding dehydration, electrolyte imbalances, and nutritional changescan help patients and clinicians address this symptom effectively while continuing therapy